Supplemental Figure S4 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma | Synapse
August 1, 2024Open Access
Supplemental Figure S4 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
The DNA-PKi enhancement of EWS cells sensitivity to etoposide DNA-PK inhibition is a class effect